Teva wins investment-grade upgrade from Moody’s

Moody’s Ratings upgraded Teva’s corporate credit rating to Baa3 from Ba1

NephroPlus Q1FY27 revenue rises 23.7% to Rs. 281.8 crore

Adjusted EBITDA climbs 30.7% to Rs. 65.1 crore as treatments cross 10.3 lakh; network expands to 550 clinics across five countries

SPARC reports Rs. 20.78 crore loss in Q1FY27

Revenue from operations rises to Rs. 39.92 crore as company reports Rs. 20.78 crore quarterly loss amid higher research and development expenses

VESCOP hosts international workshop on regulatory milestones in drug development

The workshop provided participants with cross-sector perspectives on regulatory, innovation and intellectual property pathways, while strengthening industry-academia engagement around the process of taking pharma innovations

Allergan Aesthetics revamps loyalty program

The company announced updates to Allergan Partner Privileges

Ind-Swift Laboratories clocks strong Q1 FY27: EBITDA jumps 2.85x and PAT doubles

The quarter marked another step in its transformation from an API-focused business into a focused, debt-free finished dosage formulations (FDF) platform

Marksans Pharma posts record Q1FY27 as EBITDA & PAT hit all-time highs

Sesderma expands India push as demand for science-backed skincare gains momentum

Our partnership with Sesderma is built on a shared commitment to scientific excellence, innovation, and delivering advanced derma-tech in India

Fermenta Biotech Q1 FY27 revenue stands at Rs. 124.3 crore, EBITDA declines 37%

Consolidated EBITDA excluding real estate stood at Rs. 22.3 crore, declining 37% YoY and 10% QoQ

India’s pharma exports rise 6.8% to US$ 8.1 billion in Q1 FY27

Drug formulations and biologicals remained the largest export category, contributing USD 5.98 billion and accounting for 73.85% of total pharmaceutical exports

Gland Pharma Q1 FY27 revenue rises 20% to Rs. 1,800 crore

Company's profit before tax increased 39% year-on-year to Rs. 435 crore, while profit after tax rose 47% to Rs. 317 crore from Rs. 215.5 crore in Q1 FY26

CPHI Milan 2026 to bring 260+ pharma leaders together, launch sustainability summit

The three-day event will bring together pharmaceutical manufacturers, biotech companies, regulators, consultants, suppliers and technology innovators

Biophore to acquire FDA-approved sterile injectable facility in Indore

The transaction is expected to close in Q4 2026, subject to applicable Indian regulatory requirements and customary closing conditions

Zydus Lifesciences Q1 FY27 revenue rises 22% to Rs. 8,017 crore; net profit falls 36%

The company invested Rs. 642 crore in R&D during the quarter, representing 8% of revenues, while organic capex stood at Rs. 585 crore

Revvity launches compact prenatal screening system to expand access beyond high-throughput labs

Bristol Myers Squibb to invest $2.3 billion in New Houston manufacturing campus

The roughly 600,000-square-foot campus at Generation Park will be designed to grow and adapt for decades

Jubilant Pharmova Q1 profit slumps 45% as margins take hit

Revenue from operations rose to Rs. 2,229 crore in Q1 FY27 from Rs. 1,901 crore a year earlier

IOL Chemicals Q1 profit soars 90% as revenue jumps 37% & exports-pharma drive growth

Revenue from operations surged 37.1% year-on-year (YoY) to Rs. 756.3 crore in Q1 FY27

Akums kicks off FY27 on strong footing as Q1 revenue jumps 13.9%

The company reported operating revenue of Rs. 1,167 crore in Q1 FY27

Gland Pharma lands major global CDMO deal, eyes $100 million annual revenue

The portfolio includes both oncology and non-oncology products, covering vials, lyophilised formulations, ampoules and pre-filled syringes